Company:  AYTU BIOSCIENCE, INC (AYTU)
Form Type:  10-Q/A
Filing Date:  5/14/2019 
CIK:  0001385818 
Address:  373 INVERNESS PARKWAY
SUITE 206
 
City, State, Zip:  ENGLEWOOD, Colorado 80112 
Telephone:  (720) 437-6580 
Fiscal Year:  06/30 
Last Trade
Last Trade: 
$0.83  
Change: 
0.1346 (19.48%)  
Trade Time: 
Dec 12  
Market Cap: 
$17.13M
Trade AYTU now with

© 2019  
Description of Business
We are a specialty pharmaceutical company focused on identifying, acquiring, and commercializing novel products that address significant patient needs. We have multiple FDA-approved products on the market, and we seek to build a portfolio of novel therapeutics that serve large medical needs, across a range of conditions, through our in-house commercial team. Our commercial infrastructure consists of a U.S.-based specialty sales force and an international distribution network with presence in approximately fifty countries. We currently are focused on commercialization of four products, (i) Natesto®, a testosterone replacement therapy, or TRT, (ii) Tuzistra®XR, a codeine based antitussive, (iii) ZolpiMistTM, a short-term insomnia treatment and (iv), MiOXSYS®, a novel in vitro diagnostic system for male infertility assessment.
Register and access this filing in:     
  FORM 10-Q/A
    PART II. OTHER INFORMATION
      Item 6. Exhibits.
    SIGNATURES
  EXHIBIT 10
  EXHIBIT 31.1
    Certification by Chief Executive Officer
  EXHIBIT 31.2
    Certification by Chief Financial Officer
  EXHIBIT 32.1
    Certification Pursuant to 18 U.S.C. Section 1350, as Adopted